Absci Corporation ABSI 深 滬
等待開盤 06-23 09:30:00 美东时间
8.40
+0.990
+13.36%
華盛通- 最 高8.5699
- 今 開7.51
- 成交量 837.05万股
- 最 低 7.47
- 昨 收 7.41
- 總市值 13.10亿
- 52周最高 8.5699
- 市盈率 靜 --
- 換手率 5.37%
- 52周最低 2.24
- 委 比 -36.56%
- 總股本 1.56亿
- 歷史最高 31.53
- 量 比 1.40
- 振 幅 14.84%
- 歷史最低 1.1111
- 每 手 1
- 風險率 1.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 大摩再上调希捷科技和西部数据目标价；多家大行首予Lincoln买入评级
今日重点评级关注：HC Wainwright & Co.：维持Elicio Therapeutics"买入"评级，目标价从17美元升至23美元；Leerink Partners：维持SAB Biotherapeutics"跑赢大市"评级，目标价从7美元升至12美元
06-16 11:34
Guggenheim Maintains Buy on Absci, Raises Price Target to $15
Guggenheim analyst Vamil Divan maintains Absci (NASDAQ:ABSI) with a Buy and raises the price target from $10 to $15.
06-15 23:13
美股牛股 | 蹭上SpaceX、登月概念！美国电池创业公司Solidion暴涨超350%；新股狂欢！SSMR上市涨超20%
蹭上SpaceX、登月概念！美国电池创业公司Solidion暴涨超350%；新股狂欢！SSMR、LFTO、INIO上市均涨超20%>>
06-05 18:45
美股大行评级 | 绩后暴跌，博通仍获11家大行上调目标价；CrowdStrike获21家大行集体上调目标价；Netskope、Veeva Systems惨遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Vivos Therapeutics"买入"评级，目标价从3美元升至3.1美元；富国银行：维持Veeva Systems"超配"评级，目标价从317美元升至320美元
06-05 11:33
Rumble, Agilon Health And Oscar Health Among Stocks Moving Higher On Thursday
Stocks had mixed performance on Thursday, Dow Jones up 793 points while Nasdaq down 232 points. Rumble rose after $270M deal.
06-04 22:53
Leerink Partners Initiates Coverage On Absci with Outperform Rating, Announces Price Target of $12
Leerink Partners analyst Mani Foroohar initiates coverage on Absci (NASDAQ:ABSI) with a Outperform rating and announces Price Target of $12.
06-04 20:38
美股大行评级 | 瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
05-29 18:09
BTIG Initiates Coverage On Absci with Buy Rating, Announces Price Target of $9
BTIG analyst Kambiz Yazdi initiates coverage on Absci (NASDAQ:ABSI) with a Buy rating and announces Price Target of $9.
05-28 18:54
AMD Reveals A $6.5 Million Marvell Bet That's Already Soaring
AMD discloses a new position in Marvell Technology in its latest 13F filing, revealing a stake that has already delivered a sharp paper gain.
05-13 22:03
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
